1. Home
  2. DRRX

DRRX

DURECT Corporation

Logo DURECT Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 11:33am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Founded: 1998 Country:
United States
United States
Employees: N/A City: CUPERTINO
Market Cap: 27.0M IPO Year: 2000
Target Price: $23.00 AVG Volume (30 days): 174.4K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.20 EPS Growth: N/A
52 Week Low/High: $0.47 - $7.46 Next Earning Date: 05-06-2024
Revenue: $8,548,000 Revenue Growth: -55.67%
Revenue Growth (this year): 27.13% Revenue Growth (next year): 69.31%

Share on Social Networks: